News and Announcements
Cure Brain Cancer Foundation – CEO Interview
- Published October 29, 2014 12:20PM UTC
- Publisher Wholesale Investor
- Categories Executive Interviews
Cure Brain Cancer Foundation is the largest dedicated funder of brain cancer research in Australia. Partnering with the research community, we are steering the national agenda for brain cancer research. Our mission is to accelerate new treatments to brain cancer patients and increase five-year survival to 50% within 10 years. Our priorities are to:
- Bring together global brain cancer stakeholders to set and agree priorities and gain consensus for the Australian research component globally and locally.
- Identify and short-list research projects on the basis of their compatibility with the CBCF research strategy.
To find out more about Cure Brain Cancer Foundation please listen to CEO, Ms Catherine Stace.
Executive Interviews
Why Are Fewer Companies Going Public?
The number of companies listing on the ASX has declined, driven by access to private capital, regulatory burdens, and market volatility. However, public markets still offer liquidity, visibility, and robust capital-raising opportunities.
A Message to Founders: A Shared Journey to 2025 – A Once in a Generation Opportunity
As we close this challenging year, let’s reflect on the resilience, lessons, and growth that brought us here. Founders, 2025 is your golden opportunity to innovate, scale, and thrive. Set your strategy, rest, and prepare to sprint into a year of unparalleled possibilities.
From Trash to Treasure: Inside Australia’s First Commercial Waste-to-Hydrogen Facility
Greenhill Energy’s pioneering waste-to-hydrogen facility marks a significant step in sustainable energy. This Australian innovation is transforming waste management into clean, valuable hydrogen, presenting investors with a unique, forward-thinking opportunity.
Backed By Leading Investment Groups and Family Offices
